GeneDx Holdings Corp. (WGS) Balance Sheet
As of 2026-06-30 (10-Q), GeneDx Holdings Corp. (WGS) reported total assets of $481.5M, total liabilities of $237.3M and shareholders' equity of $244.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $60.3M. Long-term debt: $96.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WGSGeneDx Holdings Corp.Follow WGS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 108.1 | 400.6 | 123.9 | 99.7 | 85.2 | 105.0 | 60.3 | |
| Short-term investments | — | — | 0.0 | 30.5 | 56.0 | 66.3 | 72.2 | |
| Receivables | 32.0 | 26.5 | 42.6 | — | 37.6 | 74.4 | 83.6 | |
| Inventory | 25.0 | 33.5 | 13.7 | 8.8 | 10.7 | 14.0 | 17.8 | |
| Current assets | 174.1 | 483.5 | 212.6 | 182.3 | 198.0 | 268.3 | 246.4 | |
| Total assets | 251.6 | 554.1 | 490.9 | 418.8 | 419.4 | 523.7 | 481.5 | |
| Current liabilities | 73.4 | 101.3 | 144.3 | 58.8 | 54.8 | 108.9 | 74.6 | |
| Long-term debt | 19.0 | 11.0 | 6.3 | 52.7 | 51.9 | 48.2 | 96.8 | |
| Short-term debt | 1.8 | 0.0 | 4.8 | 0.5 | 1.2 | 4.5 | 0.0 | |
| Total liabilities | 247.3 | 166.0 | 237.2 | 190.7 | 174.1 | 215.5 | 237.3 | |
| Shareholders' equity | -330.1 | 388.1 | 253.7 | 228.0 | 245.2 | 308.2 | 244.2 |
USD millions · SEC XBRL
GeneDx Holdings Corp. — questions
- How much cash does GeneDx Holdings Corp. have?
- $60.3M in cash and cash equivalents as of 2026-06-30.
- How much debt does GeneDx Holdings Corp. have?
- $96.8M of long-term debt and $0 due within a year as of 2026-06-30.
- What are GeneDx Holdings Corp.'s total assets?
- $481.5M as of 2026-06-30.
- What is GeneDx Holdings Corp.'s shareholders' equity?
- $244.2M as of 2026-06-30.
Every figure on this page comes from GeneDx Holdings Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.